Drugs Health Pharma

FDA clears Asahi Kasei’s oral drug to treat herpes virus in immunodeficient

The US Food and Drug Administration has approved Asahi Kasei Therapeutics, Inc’s oral drug to treat mucocutaneous lesions caused by herpes simplex virus.

Read More
Drugs Health Pharma

Fusion of brain cells after COIVID-19 infection may cause ‘brain fog’: Study

HQ Team June 8, 2023: The COVID-19 virus can fuse the brain cells that may lead to disruption in cell-to-cell communication resulting in.

Read More